ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SILO vs PRFX // DIVIDEND YIELD & FCF PAYOUT SAFETY

Silo Pharma Inc. (NASDAQ) VS. PRF Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: SILO 1 — PRFX 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SILO VS. PRFX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SILO PRFX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 38.60% -30.00% +68.60 SILO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 0.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.1 36.6 -2.46 PRFX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.4M $2.6M -$246.0K PRFX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SILO REV PRFX REV SILO GROSS % PRFX GROSS % SILO FCF PRFX FCF
FY 2025 $72.1K $17.0K 38.6% -50.0% -$4.7M -$4.0M
FY 2024 $72.1K $0 91.9% — -$3.8M -$12.6M
FY 2023 $72.1K $0 — — -$3.2M -$6.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SILO // BETA —
PRFX // BETA —